Summary & Overview
CPT 96920: Laser Treatment for Psoriasis, Area <250 sq cm
CPT code 96920 represents laser treatment for inflammatory skin disease, specifically psoriasis, when the total area treated is less than 250 square centimeters. This procedure is commonly performed in dermatology offices and offers a focused therapeutic option for patients with localized psoriasis. The code is nationally recognized and covered by major payers including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, reflecting its clinical relevance and widespread adoption.
This publication provides a comprehensive overview of 96920, detailing its clinical context, payer coverage, and associated billing practices. Readers will gain insight into typical sites of service, common modifiers used in billing, and related CPT codes for larger treatment areas. The summary also highlights relevant ICD-10 diagnoses linked to psoriasis, ensuring clarity on appropriate clinical indications. Policy updates and benchmarks are discussed to inform stakeholders about current trends and requirements for reimbursement. The analysis is designed for a national audience, offering a clear understanding of how 96920 fits within dermatology procedures and payer policies.
CPT Code Overview
CPT code 96920 is used to report laser treatment for inflammatory skin disease (psoriasis) when the total treated area is less than 250 square centimeters. This procedure falls under the Dermatology – Specials/Procedures service type and is typically performed in an office setting (Place of Service 11). The code is designed to capture targeted laser therapy for patients with localized psoriasis, providing a minimally invasive option for disease management within a clinical environment.
Clinical & Coding Specifications
Clinical Context
A patient with moderate psoriasis presents to a dermatology office for evaluation and management. The affected skin area is less than 250 square centimeters, typically involving localized plaques on the elbows, knees, or scalp. After assessment, the dermatologist determines that targeted laser therapy is appropriate to reduce inflammation and improve skin appearance. The procedure is performed in the office setting, using specialized laser equipment to treat the designated area. The patient may require multiple sessions depending on response and disease severity.
Coding Specifications
-
Modifier
51(Multiple Procedures):- Used when more than one procedure is performed during the same session by the same provider. Indicates that
96920is one of several procedures.
- Used when more than one procedure is performed during the same session by the same provider. Indicates that
-
Modifier
59(Distinct Procedural Service):- Used to identify procedures/services that are not normally reported together, but are appropriate under the circumstances. Indicates that
96920is distinct from other services performed.
- Used to identify procedures/services that are not normally reported together, but are appropriate under the circumstances. Indicates that
| Provider Taxonomy Code | Specialty Name |
|---|---|
207N00000X | Dermatology Physician |
207ND0101X | MOHS-Micrographic Surgery Physician |
207NS0135X | Pediatric Dermatology Physician |
Related Diagnoses
-
L40.0- Psoriasis vulgaris- Most common form of psoriasis, characterized by well-defined plaques. Directly relevant for laser treatment.
-
L40.8- Other psoriasis- Includes less common variants of psoriasis that may also benefit from laser therapy.
-
L40.9- Psoriasis, unspecified- Used when the specific type of psoriasis is not documented. Still appropriate for laser treatment.
-
L41.0- Pustulosis palmaris et plantaris- Psoriasis variant affecting palms and soles, often treated with laser for localized lesions.
-
L41.1- Generalized pustular psoriasis- Severe form with widespread pustules; laser may be used for localized areas within the total affected skin.
Related CPT Codes
-
96921- Laser treatment for inflammatory skin disease (psoriasis); 250 sq cm to 500 sq cm- Used when the treated area is larger than 250 sq cm but less than or equal to 500 sq cm. Selected instead of
96920when the area is within this range.
- Used when the treated area is larger than 250 sq cm but less than or equal to 500 sq cm. Selected instead of
-
96922- Laser treatment for inflammatory skin disease (psoriasis); over 500 sq cm- Used for extensive psoriasis requiring laser treatment over an area greater than 500 sq cm. Selected as an alternative to
96920for larger treatment areas.
- Used for extensive psoriasis requiring laser treatment over an area greater than 500 sq cm. Selected as an alternative to
These codes are alternatives to 96920 based on the size of the area treated. Only one code is selected per session, depending on the total area treated. They are not typically used together in the same encounter.
National Reimbursement Benchmarks
For CPT code 96920, the national mean rate for Medicare is $143.82, while the BUCA (average commercial) mean rate is higher at $155.46. Commercial payers such as UnitedHealth Group and Cigna show even greater mean rates, with UnitedHealth Group at $214.20 and Cigna at $179.49, indicating a significant premium over Medicare rates.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies notably across payers. Medicare exhibits the tightest range at $18.00, reflecting more consistent reimbursement. In contrast, UnitedHealth Group has the widest dispersion at $110.22, suggesting substantial variability in rates. Blue Cross Blue Shield and Cigna also show considerable spread, with ranges of $68.33 and $98.17, respectively.
The table and chart below present the full breakdown of national benchmarks for CPT code 96920 across major payers.
State Benchmarks
State: AK1 / 50
Alaska Benchmarks
Alaska exhibits a substantial rate spread for CPT code 96920 across payers, with Blue Cross Blue Shield showing the widest range between the 25th and 75th percentiles ($132.07), and Cigna displaying a notable spread as well ($144.50). UnitedHealth Group's rates are tightly clustered, with only an $11 difference between the 25th and 75th percentiles, indicating less variability. Commercial payers in Alaska consistently reimburse at rates far above their national averages, with UnitedHealth Group and Blue Cross Blue Shield leading the deviation.
The table and chart below present the full breakdown of mean rates and percentile values for each payer in Alaska. This comparison highlights the significant premium paid by commercial insurers in Alaska relative to both Medicare and national benchmarks.
Key Insights for Alaska
- UnitedHealth Group is the highest paying payer in Alaska for CPT 96920, with a mean rate of $353.95.
- Medicare is the lowest paying payer, with a mean rate of $138.28, significantly below commercial payers.
- All commercial payers in Alaska reimburse at rates well above their respective national averages, with UnitedHealth Group and Blue Cross Blue Shield showing the largest deviations.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.